Literature DB >> 23997565

Fusobacterium necrophorum in an Abdominal Aortic Aneurysm, Treated by Once Daily Ertapenem.

D Wotherspoon1, J A Street, S Hedderwick, R Baker.   

Abstract

Inflammatory aneurysms may make up a small percentage of the total number of abdominal aortic aneurysms, but they present their own unique challenges. We present a case of a 65-year-old man whose aneurysm was found to be colonized by Fusobacterium necrophorum.

Entities:  

Keywords:  C-reactive protein; abdominal aortic aneurysm; aneurysm; infection; mycotic aneurysm; repair; risk factors

Year:  2012        PMID： 23997565      PMCID： PMC3578632          DOI： 10.1055/s-0032-1325169

Source DB:  PubMed          Journal:  Int J Angiol        ISSN： 1061-1711


  5 in total

1.  Inflammatory abdominal aortic aneurysm.

Authors:  David B Hellmann; David J Grand; Julie A Freischlag
Journal:  JAMA       Date:  2007-01-24       Impact factor: 56.272

2.  Lemierre syndrome and nosocomial transmission of Fusobacterium necrophorum from patient to physician.

Authors:  J Bonhoeffer; D Trachsel; J Hammer; E Nava; U Heininger
Journal:  Klin Padiatr       Date:  2010-09-22       Impact factor: 1.349

Review 3.  The evolution of Lemierre syndrome: report of 2 cases and review of the literature.

Authors:  Julio A Chirinos; Daniel M Lichtstein; Javier Garcia; Leonardo J Tamariz
Journal:  Medicine (Baltimore)       Date:  2002-11       Impact factor: 1.889

Review 4.  Human infection with Fusobacterium necrophorum (Necrobacillosis), with a focus on Lemierre's syndrome.

Authors:  Terry Riordan
Journal:  Clin Microbiol Rev       Date:  2007-10       Impact factor: 26.132

5.  Anaerobic bacteria as a cause of mycotic aneurysm of the aorta: microbiology and antimicrobial therapy.

Authors:  Itzhak Brook
Journal:  Curr Cardiol Rev       Date:  2009-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.